Related Experiment Video

Updated: Jun 6, 2026

A Metadata Extraction Approach for Clinical Case Reports to Enable Advanced Understanding of Biomedical Concepts
07:50

A Metadata Extraction Approach for Clinical Case Reports to Enable Advanced Understanding of Biomedical Concepts

Published on: September 20, 2018

Pediatric Behcet's disease and thromboses

Brice Krupa1, Rolando Cimaz, Seza Ozen

  • 1Service de Pédiatrie Générale, Hématologie et Rhumatologie Pédiatrique, Hôpital Bicêtre, 78 rue Général Leclerc, 94270 Le Kremlin Bicêtre, France.

The Journal of Rheumatology
|November 17, 2010
PubMed

Insights

Thrombosis is a serious complication in pediatric Behçet's disease (BD), often occurring early. This study describes thrombosis characteristics in children with BD, highlighting common sites and treatment approaches.

Area of Science:

  • Pediatric Rheumatology
  • Vascular Medicine
  • Rare Diseases

Background:

  • Behçet's disease (BD) is a rare multisystem inflammatory disorder.
  • Thrombosis is a significant and potentially severe complication in pediatric BD.
  • Understanding thrombosis patterns in children with BD is crucial for early diagnosis and management.

Purpose of the Study:

  • To characterize pediatric patients with Behçet's disease experiencing at least one thrombotic event.
  • To identify common sites and risk factors associated with thrombosis in this population.

Main Methods:

  • Retrospective chart review of clinical, biological, and radiological data.
  • Inclusion of patients from an international pediatric BD cohort and French centers.
  • Analysis of diagnostic criteria, thrombosis locations, thrombophilia screening, and treatments.

Main Results:

  • Twenty-one pediatric BD patients with thrombosis were analyzed.
  • Cerebral sinuses (52.4%) and lower limbs (40.9%) were the most frequent thrombosis sites.
  • Thrombophilia screening was often normal, but some patients had positive anticardiolipin antibodies or protein C deficiency.

Conclusions:

  • Thrombosis is a serious, potentially early complication of pediatric Behçet's disease.
  • While thrombophilic markers may play a role, larger studies are needed to confirm risk factors.
  • An international pediatric BD cohort (PED-BD) will enable longitudinal studies on thrombosis risk.
Abstract

More Related Videos

A Thrombotic Stroke Model Based On Transient Cerebral Hypoxia-ischemia06:01

A Thrombotic Stroke Model Based On Transient Cerebral Hypoxia-ischemia

Published on: August 18, 2015

Related Concept Videos

Disorders of Hemostasis01:24

Disorders of Hemostasis

Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Sexually Transmitted Infections01:26

Sexually Transmitted Infections

Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Portal Hypertension01:22

Portal Hypertension

Portal hypertension is an increase in blood pressure within the portal venous system. Normally, this pressure is less than 5 mmHg. It is considered clinically significant when it rises above 10 mmHg. At this threshold, complications from altered blood flow and venous congestion emerge.EtiologyPortal hypertension arises from conditions that impede blood flow through the liver. The most common cause is cirrhosis, in which chronic liver injury leads to fibrotic scarring. This fibrosis narrows or...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...